Consensus Statement on Pediatric Disaster Medicine Research Priorities

Yae Sul Jeong1,2, Cullen Clark1,2, Charmaine Lo1

  • 1Division of Emergency Medicine, Nationwide Children's Hospital, Columbus, Ohio.

JAMA Network Open
|April 28, 2026
PubMed

Insights

Children in the US face disproportionate disaster impacts. A new pediatric disaster medicine research agenda prioritizes preparedness, mental health, and health equity to improve child safety during emergencies.

Area of Science:

  • Disaster Medicine
  • Pediatric Health
  • Public Health Policy

Background:

  • Children in the US are disproportionately affected by disasters.
  • Pediatric-specific disaster medicine research is limited, highlighting a critical need for a focused research agenda.
  • Improving outcomes and preparedness for future events requires a dedicated pediatric focus.

Purpose of the Study:

  • To establish an expert consensus-driven research agenda for pediatric disaster medicine in the US.
  • To guide the field of pediatric disaster medicine over the next decade.
  • To address identified gaps in research for disaster preparedness and response for children.

Main Methods:

  • A modified Delphi process involving 48 pediatric healthcare and disaster medicine experts was conducted.
  • Data collection occurred between July 1 and July 17, 2024, involving 3 rounds of surveys, discussions, and voting.
  • A deductive approach was used to analyze transcripts and refine quantitative results for consensus.

Main Results:

  • A total of 261 research questions/areas were generated and categorized into 5 main topics and 20 subtopics.
  • Five subtopics achieved high priority and high consensus: capacity/capability, community involvement, health equity, mental health, and technology.
  • Additional high priority areas included disaster metrics, research infrastructure, methodology, infectious diseases, and natural disasters.

Conclusions:

  • A national consensus research agenda for pediatric disaster medicine was established using a modified Delphi process.
  • This agenda provides a roadmap for future research, enhancing evidence-based practices.
  • The research agenda aims to improve the health and safety of pediatric populations during disasters.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
405
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
1.2K